Type 1 diabetes is caused by the immune system attacking and destroying the insulin-producing cells in the pancreas. It is not caused by eating too much sugar, being overweight, or any lifestyle choice. The process is autoimmune, meaning your own body’s defense system mistakenly targets healthy cells, and it unfolds over months or years before symptoms ever appear.
The Immune System Attacks the Pancreas
Your pancreas contains clusters of cells called islets, and within those islets are beta cells, which are the only cells in your body that produce insulin. In type 1 diabetes, the immune system identifies these beta cells as threats and begins destroying them. Immune cells that normally fight infections instead target the pancreas, gradually wiping out its ability to make insulin.
Insulin is the hormone that moves sugar from your blood into your cells for energy. As more beta cells are destroyed, insulin production drops. Once enough beta cells are gone, blood sugar rises uncontrollably and symptoms appear: extreme thirst, frequent urination, unexplained weight loss, and fatigue. By the time most people are diagnosed, a significant portion of their beta cells are already destroyed.
Genetics Set the Stage
Not everyone’s immune system turns on the pancreas. Whether it does depends heavily on your genes. The strongest genetic link involves a set of genes called the HLA region, which controls how the immune system recognizes the body’s own cells versus foreign invaders. Certain variants of these genes, particularly in the HLA class II group (DR and DQ types), dramatically increase susceptibility. These are the most variable genes in the human genome, which is part of why type 1 diabetes risk differs so much from person to person.
Having a family member with type 1 diabetes raises your risk 8 to 15 times compared to the general population. Interestingly, the risk isn’t equal between parents. Children of fathers with type 1 diabetes are roughly four times more likely to develop it than children of mothers with the condition. By age 20, about 6% of children born to fathers with type 1 had developed it, compared to about 1.3% of children born to mothers with type 1. Researchers believe mothers may pass along some form of immune protection during pregnancy, though the exact mechanism is still being studied.
Still, most people diagnosed with type 1 diabetes have no family history at all. Carrying the genetic risk is necessary but not sufficient on its own. Something else has to trigger the immune attack.
Viral Infections as a Likely Trigger
The leading candidates for that trigger are viral infections, especially a group called enteroviruses. These are common viruses that infect the gut, and most people encounter them without lasting harm. But in genetically susceptible individuals, certain enterovirus strains, particularly coxsackievirus B types, appear to set off the autoimmune process that targets beta cells.
A large meta-analysis of 60 studies covering more than 12,000 people found that enterovirus detection was twice as high in individuals who developed early signs of the autoimmune attack. Among those who eventually progressed to type 1 diabetes, the odds of enterovirus detection were over five times higher than in controls. The strongest signal appeared around the time of diagnosis: in people newly diagnosed with type 1, the odds of finding enterovirus were more than 16 times higher than in people without the disease.
The working theory is that a viral infection in the pancreas or gut triggers an immune response that, in people with the right genetic background, spills over into an attack on beta cells. The virus itself doesn’t cause diabetes directly. It acts more like a match in a room that was already primed to ignite.
Three Stages Before Diagnosis
Type 1 diabetes doesn’t happen overnight. Researchers now describe it as progressing through three distinct stages, and the first two have no symptoms at all.
In Stage 1, the immune attack has started. Blood tests can detect autoantibodies, which are immune proteins targeting beta cells. But insulin production is still adequate, blood sugar levels are normal, and you would feel completely fine. This stage can last for years.
In Stage 2, the ongoing destruction of beta cells begins to affect blood sugar regulation. Blood sugar levels become abnormal, particularly after meals or during glucose tolerance testing. Two or more types of autoantibodies are present. There are still no noticeable symptoms, which is why this stage is only caught through screening.
Stage 3 is when most people receive their diagnosis. Enough beta cells have been destroyed that the body can no longer maintain blood sugar on its own. This is when the classic symptoms hit, often rapidly and sometimes severely. The progression from Stage 1 to Stage 3 varies widely. Some people move through all three stages within a year or two. Others remain in Stage 1 for a decade or more.
It’s Not Just a Childhood Disease
Type 1 diabetes is often associated with children, and it is the most common form of diabetes diagnosed in kids and teens. But adults develop it too. A slower-moving form called latent autoimmune diabetes in adults (sometimes called type 1.5 diabetes) is typically diagnosed between ages 30 and 50. The underlying cause is the same: autoantibodies attack the beta cells. The difference is pace. In children, beta cell destruction tends to be rapid and dramatic. In LADA, the pancreas loses function gradually, sometimes over months or years.
This slow progression means LADA is frequently misdiagnosed as type 2 diabetes. Studies suggest that 4% to 12% of people initially told they have type 2 actually have LADA. The distinction matters because people with LADA will eventually need insulin, while many type 2 treatments focus on improving insulin sensitivity rather than replacing insulin the body can no longer make.
Sugar and Lifestyle Don’t Cause It
One of the most persistent misconceptions about type 1 diabetes is that it’s caused by diet, sugar consumption, or lack of exercise. It is not. Type 1 is an autoimmune disease driven by genetics and environmental triggers like viral infections. There is no known way to prevent it, and no lifestyle change can stop the immune attack once it begins. This is fundamentally different from type 2 diabetes, where weight, activity level, and diet play significant roles. The two diseases share a name but have different causes.
Screening and Early Intervention
Because the autoimmune process starts long before symptoms appear, screening with autoantibody blood tests can identify people in Stage 1 or Stage 2. This is most commonly done for first-degree relatives of people with type 1 diabetes, since their risk is substantially higher.
Early identification now has a practical benefit beyond just knowing your risk. An immunotherapy drug called teplizumab became the first treatment approved to delay the onset of clinical type 1 diabetes. In a trial of 76 participants who had two or more autoantibodies and abnormal blood sugar (Stage 2), a 14-day course of the drug delayed diagnosis by a median of two years. Among the control group, 72% progressed to clinical diabetes, compared to 43% in the treatment group. Those in the treatment group who did eventually develop clinical diabetes took a median of 48 months to reach that point, compared to 24 months for the placebo group. The drug works by calming the specific immune cells responsible for attacking beta cells, buying the pancreas more functional time.
For families with a history of type 1 diabetes, autoantibody screening through programs like TrialNet can catch the disease in its silent early stages, when intervention has the best chance of making a difference.